The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

Objectives: Disease severity, previous medications and immunosuppressive agents could affect the antibody response against SARS-CoV-2. This study aimed to analyze variables affecting the humoral response to SARS-CoV-2. Methods: This prospective cohort study included adult patients who recovered from...

Full description

Bibliographic Details
Main Authors: Seniha Başaran, Serap Şimşek-Yavuz, Sevim Meşe, Atahan Çağatay, Alpay Medetalibeyoğlu, Oral Öncül, Halit Özsüt, Ali Ağaçfidan, Ahmet Gül, Haluk Eraksoy
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:International Journal of Infectious Diseases
Subjects:
Tocilizumab
Anakinra
Prednisolone
SARS-CoV-2
Antibody
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221002496

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221002496

Similar Items